Aethlon Medical (AEMD)

• Market cap: $4.86M
• 1 day: -5.44%
• 5 days: 8.47%
• 1 month: -35.87%
• 3 months: -59.38%
• 6 months: -75.71%
• Year to date: -88.58%
• 1 year: -76.34%
• 5 years: -99.39%
• 10 years: -99.99%
• Sector: Healthcare
• Industry: Medical Devices

About: Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.

Employees: 9

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

13.47% more ownership

Funds ownership: 2.05% [Q1] → 15.52% (+13.47%) [Q2]

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

30% less funds holding

Funds holding: 23 [Q1] → 16 (-7) [Q2]

60% less capital invested

Capital invested by funds: $1.21M [Q1] → $481K (-$729K) [Q2]

78% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 9

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $1.5
• Avg. target: $1.5
• High target: $1.5

1 analyst rating

• positive: 0 0%
• neutral: 1 100%
• negative: 0 0%

HC Wainwright & Co. Swayampakula Ramakanth

$1.5

Neutral Reiterated

14 Aug 2025